213 related articles for article (PubMed ID: 29484697)
1. Risk of new-onset diabetes mellitus during treatment with low-dose statins in Japan: A retrospective cohort study.
Kato S; Miura M
J Clin Pharm Ther; 2018 Aug; 43(4):536-542. PubMed ID: 29484697
[TBL] [Abstract][Full Text] [Related]
2. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
[TBL] [Abstract][Full Text] [Related]
3. New onset diabetes mellitus induced by statins: current evidence.
Chrysant SG
Postgrad Med; 2017 May; 129(4):430-435. PubMed ID: 28276790
[TBL] [Abstract][Full Text] [Related]
4. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
[TBL] [Abstract][Full Text] [Related]
5. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use.
Shin J; Kim H; Yim HW; Kim JH; Lee S; Kim HS
J Clin Pharm Ther; 2022 Jan; 47(1):97-103. PubMed ID: 34668200
[TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.
Ooba N; Setoguchi S; Sato T; Kubota K
BMJ Open; 2017 Jun; 7(6):e015935. PubMed ID: 28667223
[TBL] [Abstract][Full Text] [Related]
8. Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis.
Kamran H; Kupferstein E; Sharma N; Karam JG; Myers AK; Youssef I; Sowers JR; Gustafson DR; Salifu MO; McFarlane SI
Cardiorenal Med; 2018; 8(2):105-112. PubMed ID: 29617000
[TBL] [Abstract][Full Text] [Related]
9. Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy.
Wang KL; Liu CJ; Chao TF; Chen SJ; Wu CH; Huang CM; Chang CC; Wang KF; Chen TJ; Lin SJ; Chiang CE
Am J Cardiol; 2014 Feb; 113(4):631-6. PubMed ID: 24360773
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
[TBL] [Abstract][Full Text] [Related]
11. Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
Ong KL; Waters DD; Messig M; DeMicco DA; Rye KA; Barter PJ
Am J Cardiol; 2014 May; 113(10):1593-8. PubMed ID: 24666618
[TBL] [Abstract][Full Text] [Related]
12. New onset diabetes mellitus and cardiovascular outcomes according to statin intensity in patients after drug-eluting stent implantation in Asian patients.
Chung J; Kim HL; Lim WH; Seo JB; Zo JH; Kim MA; Kim SH
Sci Rep; 2023 Sep; 13(1):16061. PubMed ID: 37749120
[TBL] [Abstract][Full Text] [Related]
13. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
14. Analysis of glycemic status in diabetes-naïve patients on statins: A hospital-based cross-sectional study.
Thomson SR; Chogtu B; Shetty R; Devasia T
Indian J Pharmacol; 2018; 50(6):320-325. PubMed ID: 30783324
[TBL] [Abstract][Full Text] [Related]
15. Comparison between high and low potency statins in the incidence of open-angle glaucoma: A retrospective cohort study in Japanese working-age population.
Ooba N; Iwahashi R; Nogami A; Nakayama T; Kanno A; Tochikura N; Ootsuka S; Fukuoka N
PLoS One; 2020; 15(8):e0237617. PubMed ID: 32804969
[TBL] [Abstract][Full Text] [Related]
16. Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.
Castro MR; Simon G; Cha SS; Yawn BP; Melton LJ; Caraballo PJ
J Gen Intern Med; 2016 May; 31(5):502-8. PubMed ID: 26850412
[TBL] [Abstract][Full Text] [Related]
17. New-Onset Diabetes After Statin Exposure in Elderly Women: The Australian Longitudinal Study on Women's Health.
Jones M; Tett S; Peeters GM; Mishra GD; Dobson A
Drugs Aging; 2017 Mar; 34(3):203-209. PubMed ID: 28138911
[TBL] [Abstract][Full Text] [Related]
18. Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms, and Clinical Implications.
Guber K; Pemmasani G; Malik A; Aronow WS; Yandrapalli S; Frishman WH
Cardiol Rev; 2021 Nov-Dec 01; 29(6):314-322. PubMed ID: 32947479
[TBL] [Abstract][Full Text] [Related]
19. Statin use increased new-onset diabetes in hypercholesterolemic individuals: Data from the Korean National Health Insurance Service-National Health Screening Cohort database (NHIS-HEALS).
Kim YS; Han YE; Choi EA; You NY; Lee JW; You HS; Kim Y; Kim J; Kang HT
Prim Care Diabetes; 2020 Jun; 14(3):246-253. PubMed ID: 31548127
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering agents and new onset diabetes mellitus.
Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
Expert Opin Pharmacother; 2010 Aug; 11(12):1965-70. PubMed ID: 20486831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
